Objective : The object of this study was to assess the outcomes of surgical treatment of stage pT1a and pT1b1 cervical cancer. 
Introduction
In nearly all cases of cervical cancer, human papillomavirus (HPV) infection is present [1] [2] [3] [4] . About 
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Patients and Methods
The database was analyzed for the period January 1996 to September 2006. Fifty-nine patients with pT1a and pT1b1 cervical cancer underwent primary treatment for cervical cancer at our institution (Table 1, Table 2, Table 3 Results Table 2 and Table 3 show the treatment No patients had any histologic subtype of adnexal metastasis in the resected specimens. Two of the five patients with SCC and lymph node metastasis at the initial operation had recurrence. All three patients with recurrence underwent post-operative adjuvant radiation therapy as the initial treatment.
One patient had recurrence in an intra-pelvic radiation treatment field. The other two patients had recurrence out of the radiation treatment field. . In 1995, the International . For depth of invasion of < 3 mm, LVSI has been reported in 4.5 -29% of patients, but increasing to 11.1-46.7% for depth of invasion of 3.1-5.0 mm 16) . The incidence of positive nodes in patients with stage I A1 disease has been reported to be 0.5-0.8% 17, 18) . The overall incidence of lymph node metastases in patients with depth of invasion of 3-5 mm has been reported as 7.1%, although this varies from 0% to 13.8% 15, [19] [20] [21] [22] [23] . Patients with 3-5 mm of invasion present at conization and with no invasion in the hysterectomy specimen are at very low risk for lymph node metastases, recurrence, or death that is caused by the cancer 15) . Six hundred fifty-five patients with 0-5 mm of invasion were treated with conization only, and only 12 (1.8%) cases of recurrence and 1 (0.1%) death were reported 15) .
In our institution, the current operative [24] [25] [26] [27] .
Ten patients underwent an operation which was less aggressive than the current operative modality ( . 
Conclusion
Based on the current evidence, these results suggest that a patient in an early stage can undergo less aggressive surgery than the current operative modality requires. As the number of the patients was few, the status necessary to minimize radicality of the operation cannot be proposed. In the future, in order to avoid unnecessary aggression, operative modality will be determined not only with stage but also with other risk factors such as gene abnormalities. 
